Scott J. C. Pallett, Alex Tasker, Danny Chambers, Michael Corley, Matthew K. O’Shea, Sally Davies, Luke S. P. Moore
{"title":"The effect of geopolitical flux on antimicrobial resistance","authors":"Scott J. C. Pallett, Alex Tasker, Danny Chambers, Michael Corley, Matthew K. O’Shea, Sally Davies, Luke S. P. Moore","doi":"10.1038/s41591-025-03758-9","DOIUrl":null,"url":null,"abstract":"<p>Changing international relationships and increasing geopolitical tensions can present very real hazards to health and healthcare, particularly in relation to communicable diseases<sup>1</sup>. Conflicts in Ukraine, Gaza and Syria have resulted in mass population displacements, and disruptions to sanitation, hygiene, health infrastructures and key public health initiatives challenge efforts to curb the spread of infectious and vaccine-preventable diseases (https://www.iom.int/crisis-ukraine; https://www.iom.int/crisis-syrian-arab-republic).</p><p>Political stability and health are closely interlinked, underlining how investments in global health can have profound impacts on humanitarian issues. Put simply, global disease surveillance and prevention are parts of a complex geopolitical tapestry, and we ignore these multiple threads at our peril. The spread of antimicrobial resistance (AMR) is a sobering illustration of such complexity and one of the greatest global health threats of our time<sup>2</sup>. In Ukraine, we have seen how AMR continues to extend hospital stays and morbidity while presenting a serious threat to health services across Europe<sup>3</sup>. International collaboration in health surveillance, therapeutic development and intelligence-sharing therefore is fundamental to limiting the spread of drug-resistant infections<sup>4</sup>.</p>","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"178 1","pages":""},"PeriodicalIF":58.7000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41591-025-03758-9","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Changing international relationships and increasing geopolitical tensions can present very real hazards to health and healthcare, particularly in relation to communicable diseases1. Conflicts in Ukraine, Gaza and Syria have resulted in mass population displacements, and disruptions to sanitation, hygiene, health infrastructures and key public health initiatives challenge efforts to curb the spread of infectious and vaccine-preventable diseases (https://www.iom.int/crisis-ukraine; https://www.iom.int/crisis-syrian-arab-republic).
Political stability and health are closely interlinked, underlining how investments in global health can have profound impacts on humanitarian issues. Put simply, global disease surveillance and prevention are parts of a complex geopolitical tapestry, and we ignore these multiple threads at our peril. The spread of antimicrobial resistance (AMR) is a sobering illustration of such complexity and one of the greatest global health threats of our time2. In Ukraine, we have seen how AMR continues to extend hospital stays and morbidity while presenting a serious threat to health services across Europe3. International collaboration in health surveillance, therapeutic development and intelligence-sharing therefore is fundamental to limiting the spread of drug-resistant infections4.
期刊介绍:
Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors.
Nature Medicine consider all types of clinical research, including:
-Case-reports and small case series
-Clinical trials, whether phase 1, 2, 3 or 4
-Observational studies
-Meta-analyses
-Biomarker studies
-Public and global health studies
Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.